This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Global Neurostimulation Industry

Devices II-35

9. RECENT INDUSTRY ACTIVITY II-37Cyberonics Collaborates with Imricor Medical for DevelopingMRI Compatible Leads II-37Boston Scientific Takes Over Intelect Medical II-37GE Healthcare Inks Distribution and Marketing Agreement withKC BioMedix II-37Cyberonics and ImThera to Develop Neurostimulation Technologyfor OSA II-38NDI Medical Establishes New Business Unit for Advancement ofIPG Technology II-38Sonova Holding Acquires Advanced Bionics II-38Medtronic Initiates Clinical Trial for RestoreSensor II-38NeuroMetrix Purchases Select Assets of CyberkineticsNeurotechnology Systems II-39St. Jude Medical Purchases Non-Cash Assets and IntellectualProperty of Northstar Neuroscience II-39Victhom Human Bionics Signs Agreement with Otto Bock HealthCare II-39Neuros Medical Collaborates with Battelle II-40JumpStart & CTV Invest in Neuros Medical II-40InterWest Invests in Autonomic Technologies II-40MicroTransponder Finalizes Series A Funding Round forWireless Neurostimulator Development II-41


Bioness Launches L300 Plus Foot Drop System in the US For

Patients with Gait Disorders II-42

St.Jude Medical Launches Penta Surgical Leads in Japan II-42

Neurotech® Introduces Kneehab® XP Quadriceps Therapy System II-42

St.Jude Medical Launches Epiducer Lead Delivery System in

Australia II-43

Neurowave Medical Technologies™ Unveils Reletex™

Neuromodulation Device II-43

ST Jude Medical Rolls out Genesis Neurostimulation System in

Japan II-43

Medtronic Unveils Brain Stimulation Products II-44

Alphalife Launches Alpha Brainwave Neurostimulator II-44

ImThera Medical Introduces aura6000™ Neurostimulation System II-44

Mobilis Healthcare Introduces InterX II-44

IMEC Develops and Models New Design for Brain Stimulation

Implants II-45

11. FOCUS ON SELECT PLAYERS II-46Bioness Inc. ( USA) II-46Boston Scientific Corp. ( USA) II-46Cyberonics, Inc. ( USA) II-46Medtronic, Inc. ( USA) II-47St. Jude Medical, Inc. ( USA) II-47Synapse Biomedical, Inc. ( USA) II-48SPR Therapeutics, LLC (US) II-48


Table 4: World Recent Past, Current & Future Analysis for

Neurostimulation by Geographic Region - US and Rest of World

Markets Independently Analyzed with Annual Sales Figures in

4 of 11

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,135.72 +38.82 0.21%
S&P 500 2,101.04 +2.51 0.12%
NASDAQ 4,982.8090 +15.6680 0.32%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs